Evidence map›Paper›PMID 33063685›Full record

ArticleAnnals of laboratory medicine2021

Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea.

Hee Jae Huh, Ki Ho Hong, Taek Soo Kim, Sang Hoon Song, Kyoung Ho Roh, Hyukmin Lee, Gye Cheol Kwon

Open access · diamondAbstract read
In one paragraph

Article in Annals of laboratory medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.4field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Hee Jae HuhDepartment of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-8999-7561
Ki Ho HongDepartment of Laboratory Medicine, Seoul Medical Center, Seoul, Korea.ORCID https://orcid.org/0000-0002-5700-9036
Taek Soo KimDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-2093-1721
Sang Hoon SongDepartment of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-5084-1137
Kyoung Ho RohDepartment of Laboratory Medicine, National Health Insurance Service Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-6291-9229
Hyukmin LeeDepartment of Laboratory Medicine, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0002-8523-4126
Gye Cheol KwonDepartment of Laboratory Medicine, College of Medicine, Chungnam National University, Daejeon, Korea.ORCID https://orcid.org/0000-0002-4886-0590
Seoul National University · KRChungnam National University · KRNational Health Insurance Service Ilsan Hospital · KRSamsung Medical Center · KRSeoul Medical Center · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In response to the ongoing coronavirus disease 2019 (COVID-19) pandemic, an online laboratory surveillance system was established to monitor severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) real-time reverse transcription-PCR (rRT-PCR) testing capacities and results. SARS-CoV-2 rRT-PCR testing data were collected from 97 clinical laboratories, including 84 medical institutions and 13 independent clinical laboratories in Korea. We assessed the testing capacities to utilize SARS-CoV-2 rRT-PCR based on surveillance data obtained from February 7th to June 4th, 2020 and evaluated positive result characteristics according to the reagents used and sample types. A total of 1,890,319 SARS-CoV-2 rRT-PCR testing were performed, 2.3% of which were positive. Strong correlations were observed between the envelope (

Indexed as

BetacoronavirusClinical Laboratory ServicesCoronavirus Envelope ProteinsCoronavirus InfectionsCOVID-19HumansLaboratories, HospitalPandemicsPneumonia, ViralReal-Time Polymerase Chain ReactionRepublic of KoreaRNA-Dependent RNA PolymeraseRNA, ViralSARS-CoV-2Viral Envelope ProteinsViral ProteinsCoronavirus Envelope Proteinsenvelope protein, SARS-CoV-2RNA-Dependent RNA PolymeraseRNA, ViralViral Envelope ProteinsViral ProteinsCoronavirus disease 2019Ct valueLaboratory surveillanceReal-time RT-PCRSevere acute respiratory syndrome coronavirus 2Testing capacity

Identifiers

PMID33063685
PMCPMC7591284
OpenAlexW3092752016

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.